Mereo BioPharma Group plc
MREO
$0.32
$0.013.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.72M | -7.35M | -7.02M | -14.62M | -12.89M |
| Total Depreciation and Amortization | 305.00K | 592.00K | -11.00K | 298.00K | 270.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -59.00K | 1.32M | -674.00K | 7.51M | 4.80M |
| Change in Net Operating Assets | 2.16M | -2.25M | 400.00K | -843.00K | -514.00K |
| Cash from Operations | -4.31M | -7.68M | -7.31M | -7.65M | -8.33M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.00K | 0.00 | 300.00K | 0.00 | -300.00K |
| Cash from Investing | -300.00K | 0.00 | 300.00K | 0.00 | -320.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 39.00K | 0.00 | 0.00 | 487.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -134.00K | -65.00K |
| Cash from Financing | -- | 39.00K | 0.00 | -134.00K | 422.00K |
| Foreign Exchange rate Adjustments | -157.00K | -63.00K | -418.00K | 1.43M | 908.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.77M | -7.71M | -7.43M | -6.36M | -7.32M |